Search research articles
Contact Us
Filters
Showing results (81-90 of 232) with videos related to
Page
of 24
Sort By:
Translational Oncology
|
August 9, 2022
Survey of Lifestyle, Past Medical History and Complementary and Alternative Medicine Use Among Adult Patients Participating in the National Cancer Institute's Exceptional Responders Initiative
Oluwadamilola Olaku, Barbara A Conley, S Percy Ivy, et al.
JCO Clinical Cancer Informatics
|
January 18, 2019
Technology Applications: Use of Digital Health Technology to Enable Drug Development
Joyce F Liu, Jung-Min Lee, Ellie Strock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials
David M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2012
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
Joanna M Brell, Smitha S Krishnamurthi, Linda Rath, et al.
Investigational New Drugs
|
July 22, 2005
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer
Afshin Dowlati, Robert Chapman, Shanmuga Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2013
Developing standards for breakthrough therapy designation in oncology
Sandra J Horning, Daniel A Haber, Wendy K D Selig, et al.
Oncotarget
|
February 17, 2015
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
David M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
The Oncologist
|
March 20, 2021
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation
Joseph W Kim, Dana B Cardin, Ulka N Vaishampayan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies
Shivaani Kummar, Larry Anderson, Kimberly Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2011
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate
Glenn Liu, Robert Jeraj, Matt Vanderhoek, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 232) with videos related to
Sort By:
Page
of 24
Translational Oncology
|
August 9, 2022
Survey of Lifestyle, Past Medical History and Complementary and Alternative Medicine Use Among Adult Patients Participating in the National Cancer Institute's Exceptional Responders Initiative
Oluwadamilola Olaku, Barbara A Conley, S Percy Ivy, et al.
JCO Clinical Cancer Informatics
|
January 18, 2019
Technology Applications: Use of Digital Health Technology to Enable Drug Development
Joyce F Liu, Jung-Min Lee, Ellie Strock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials
David M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2012
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
Joanna M Brell, Smitha S Krishnamurthi, Linda Rath, et al.
Investigational New Drugs
|
July 22, 2005
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer
Afshin Dowlati, Robert Chapman, Shanmuga Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2013
Developing standards for breakthrough therapy designation in oncology
Sandra J Horning, Daniel A Haber, Wendy K D Selig, et al.
Oncotarget
|
February 17, 2015
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
David M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
The Oncologist
|
March 20, 2021
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation
Joseph W Kim, Dana B Cardin, Ulka N Vaishampayan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies
Shivaani Kummar, Larry Anderson, Kimberly Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2011
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate
Glenn Liu, Robert Jeraj, Matt Vanderhoek, et al.
Page
of 24